Viewing data from:

LUFYLLIN

ANDA

DYPHYLLINE | A084566 | PHARMOBEDIENT CONSULTING LLC

2 strengths0 unique patents0 unique exclusivities

API Supply Chain1 active DMF1 inactive

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

SHANGHAI WONDER PHARMACEUTICAL CO LTDDYPHYLLINE

DMF 346792020

CENTRAL PHARMACAL COInactiveDYPHYLLINE SUSTAINED RELEASE CAPSULES

DMF 37931980

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 200MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.

#002 — 400MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Approved Prior to Jan 1, 1982